Skip to main content
. 2012 Aug 31;80(4):1061–1080. doi: 10.3797/scipharm.1208-02

Tab. 1.

Characterization of elastic liposomal formulations

S. No. Formulation code Entrapment efficiency (%) No. of vesicles per mm3 1000 X PDI Drug content (%) Turbidity (NTU)
1. EL-SP1 23±0.12 35±0.34 0.442±0.04 97.4±0.34 15.2±0.12
2. EL-SP2 41±0.14 39±0.23 0.392±0.05 98.5±0.23 19.7±0.32
3. EL-SP3 79±0.43 45±0.32 0.376±0.02 98.7±0.32 23.1±0.43
4. EL-SP4 90.4±0.15 52±0.21 0.338±0.08 99.6±0.21 27.4±0.33
5. EL-SP5 87±0.32 32±0.27 0.467±0.10 97.9±0.27 24.2±0.17

Data are represent of mean ± SD (n=3).